Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2025)
Fennec Pharmaceuticals (FENC) posted Non-Current Assets of $3.5 million for Q4 2025, up 9.73% on a QoQ basis from $3.2 million in Q3 2025, and up 326.76% year-over-year from $822000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Non-Current Assets history runs 7 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- Quarterly Non-Current Assets rose 326.76% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 326.76% YoY) and the FY2025 annual result came in at $3.5 million, up 326.76% from the prior year.
- Non-Current Assets was $3.5 million for Q4 2025 at Fennec Pharmaceuticals, up from $3.2 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $4.1 million in Q2 2025 and bottomed at $6000.0 in Q4 2023.
- A 5-year average of $998421.1 and a median of $211000.0 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets plunged 97.16% — and 2024, when it soared 13600.0%.
- Fennec Pharmaceuticals' Non-Current Assets stood at $27000.0 in 2021, then jumped by 681.48% to $211000.0 in 2022, then plunged by 97.16% to $6000.0 in 2023, then surged by 13600.0% to $822000.0 in 2024, then jumped by 326.76% to $3.5 million in 2025.
- Business Quant data shows FENC's Non-Current Assets at $3.5 million in Q4 2025, $3.2 million in Q3 2025, and $4.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Jun 30, 2020 | 417,000.00 |